Lunai Bioworks Price to Free Cash Flow Ratio 2013-2026 | LNAI
Historical price to free cash flow ratio values for Lunai Bioworks (LNAI) since 2013.
| Lunai Bioworks Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-16 | 2.17 | 0.00 | |
| 2026-03-31 | 3.26 | $-1.96 | 0.00 |
| 2025-12-31 | 7.06 | $-2.38 | 0.00 |
| 2025-09-30 | 11.36 | $-3.29 | 0.00 |
| 2025-06-30 | 23.12 | $-3.82 | 0.00 |
| 2025-03-31 | 43.44 | $-5.72 | 0.00 |
| 2024-12-31 | 66.88 | $-4.07 | 0.00 |
| 2024-09-30 | 38.64 | $-6.62 | 0.00 |
| 2024-06-30 | 140.00 | $-9.06 | 0.00 |
| 2024-03-31 | 212.00 | $-9.45 | 0.00 |
| 2023-12-31 | 253.60 | $-15.05 | 0.00 |
| 2023-09-30 | 357.60 | $-16.38 | 0.00 |
| 2023-06-30 | 45.36 | $-16.78 | 0.00 |
| 2023-03-31 | 73.20 | $-18.32 | 0.00 |
| 2022-12-31 | 82.40 | $-17.80 | 0.00 |
| 2022-09-30 | 144.80 | $-19.73 | 0.00 |
| 2022-06-30 | 154.40 | $-23.97 | 0.00 |
| 2022-03-31 | 660.00 | $-41.34 | 0.00 |
| 2021-12-31 | 583.20 | $-41.16 | 0.00 |
| 2021-09-30 | 538.40 | $-38.40 | 0.00 |
| 2021-06-30 | 397.60 | $-35.04 | 0.00 |
| 2021-03-31 | 283.20 | $-16.86 | 0.00 |
| 2020-12-31 | 236.00 | $-19.61 | 0.00 |
| 2020-09-30 | 286.40 | $-19.88 | 0.00 |
| 2020-06-30 | 336.80 | $-18.38 | 0.00 |
| 2020-03-31 | 240.00 | $-19.00 | 0.00 |
| 2019-12-31 | 401.60 | $-18.17 | 0.00 |
| 2019-09-30 | 440.00 | $-18.23 | 0.00 |
| 2019-06-30 | 360.00 | $-19.65 | 0.00 |
| 2019-03-31 | 555.20 | $-22.19 | 0.00 |
| 2018-12-31 | 560.00 | $-19.45 | 0.00 |
| 2018-09-30 | 467.20 | $-17.39 | 0.00 |
| 2018-06-30 | 265.60 | $-15.93 | 0.00 |
| 2018-03-31 | 440.00 | $-10.88 | 0.00 |
| 2017-12-31 | 47.50 | $-7.96 | 0.00 |
| 2017-09-30 | 35.00 | $-8.14 | 0.00 |
| 2017-06-30 | 152.00 | $-7.68 | 0.00 |
| 2017-03-31 | 96.00 | $-8.30 | 0.00 |
| 2016-12-31 | 15.00 | $-8.73 | 0.00 |
| 2016-09-30 | 220.00 | $-11.60 | 0.00 |
| 2016-06-30 | 200.00 | $-12.35 | 0.00 |
| 2016-03-31 | 15.00 | $-38.58 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |